BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 15239091)

  • 1. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
    Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
    Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
    Weston SJ; Leistikow RL; Reddy KR; Torres M; Wertheimer AM; Lewinsohn DM; Chou S; Davey MP; Corless C; O'Farrelly C; Nelson DR; Rosen HR
    Hepatology; 2005 Jan; 41(1):72-81. PubMed ID: 15619226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.
    Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C
    Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.
    García-Bengoechea M; Basaras M; Barrio J; Arrese E; Montalvo II; Arenas JI; Cisterna R
    Am J Gastroenterol; 1999 Jul; 94(7):1902-5. PubMed ID: 10406257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.
    Folgori A; Spada E; Pezzanera M; Ruggeri L; Mele A; Garbuglia AR; Perrone MP; Del Porto P; Piccolella E; Cortese R; Nicosia A; Vitelli A;
    Gut; 2006 Jul; 55(7):1012-9. PubMed ID: 16484505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.
    Woollard DJ; Grakoui A; Shoukry NH; Murthy KK; Campbell KJ; Walker CM
    Hepatology; 2003 Nov; 38(5):1297-306. PubMed ID: 14578870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.
    Aberle JH; Formann E; Steindl-Munda P; Weseslindtner L; Gurguta C; Perstinger G; Grilnberger E; Laferl H; Dienes HP; Popow-Kraupp T; Ferenci P; Holzmann H
    J Clin Virol; 2006 May; 36(1):24-31. PubMed ID: 16483838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.
    Grüner NH; Gerlach TJ; Jung MC; Diepolder HM; Schirren CA; Schraut WW; Hoffmann R; Zachoval R; Santantonio T; Cucchiarini M; Cerny A; Pape GR
    J Infect Dis; 2000 May; 181(5):1528-36. PubMed ID: 10823750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
    Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
    Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.
    Nelson DR; Marousis CG; Ohno T; Davis GL; Lau JY
    Hepatology; 1998 Jul; 28(1):225-30. PubMed ID: 9657116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ; Xie Y; Li ZQ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
    Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
    Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.